ABSTRACT
Background: Measles Rubella (MR) immunization coverage for schoolers in Semarang City decreased to 92.7% in 2020 due to the COVID-19 pandemic. However, in practice, many parents still complain about MR immunization services for schoolers. Aims: This study aimed to determine parental satisfaction with MR immunization services during the COVID-19 pandemic. Methods: This quantitative study used a cross-sectional approach. Purposive and proportional sampling was used to select 102 samples. Data collection was done through questionnaire, and data were analyzed using the chi-square test and importance-performance analysis test. Results: The lowest suitability dimension level was tangibility (81.52%), followed by responsiveness (86.6%). The reliability dimension had the highest average conformity level (92.87%). The priority items for improvement were related to health workers' compliance with the use of complete personal protective equipment (PPE), spacious immunization service rooms, registration officers' responsiveness in giving directions, punctual immunizations distribution, polite and friendly registration services officers, as well as health workers' initiative to remind parents about health protocols. Bivariate analysis showed there was no relationship between respondents' characteristics and their satisfaction level. Conclusion: Parental satisfaction with MR immunization services for schoolers did not match their expectations;therefore, it is necessary to improve future immunization services. © 2022, Airlangga University. All rights reserved.
ABSTRACT
The goal of the immunization program is to provide protection from diseases that can be prevented by immunization (PD3I), such as tuberculosis, diphtheria, tetanus, polio, hepatitis B, and measles. Therefore, optimizing the immunization coverage is very important. The coverage of complete basic immunization in Pekalongan District decreased to 88.4% in 2017, while 7 cases of measles were still found. Further, the coverage of immunization has been a challenge in the COVID-19 pandemic situation. The objective of this study was to analyze the complete basic immunization coverage in Pekalongan Regency using Rapid Card Check. This study used an analytic observational design with quantitative and qualitative approaches. Quantitative analysis was performed using chi-square analysis, while in-depth interviews carried out a qualitative analysis to explore further the reasons for not having immunization. The number of samples was 535 toddlers aged 10-26 months. The sample was selected based on random sampling techniques, and data were collected using Rapid Card Check instrument. The coverage of immunization was 71.6%, and only 2.1% did the immunization correctly. Based on the type of antigen, the highest immunization coverage was HB0 = 88.4%, and the lowest was measles = 74.4%. The highest immunization accuracy was the type of antigen HB0 = 85.4%, and the lowest one was Polio4 = 12.0%. The coverage of complete basic immunization in Pekalongan District is still below the national target (95%) in the Covid-19 pandemic era. Therefore, intensive efforts should be made to increase the coverage in the current ear © 2022 by SPC (Sami Publishing Company)
ABSTRACT
Coronavirus Disease-2019 (COVID-19) is a pandemic disease in all over the world caused by SARS-COV-2 virus. This disease also spread all over Indonesia. The cost of treating People Under Surveillance and Patient under Monitoring, also confirmed patient of COVID-19 will be financed by the Indonesian Government. This research aimed to identify the estimated cost for treating the Covid-19 patients in Indonesia. The calculation method used top up costs and INA CBGs based on the number of hospitalized positive patients. The data source was COVID-19 data in Central Java and national data. Case growth calculated by doubling time positive cases of COVID-19 in Central Java were 1.7 (range 1.73 - 2.73). Range of days was between 6-8 days. The amount of top up cost for one day treatment refers to Health Ministry of Indonesia Decree Number HK.01.07/MENKES/238/2020 and cost estimation of INACBGs with the severity level II and III. This calculation did not include donations, outpatients and other costs. The result of this study, estimation if patients were treated in ICU for 8 days and non ICU for 7 days, and the rest of inpatients according to INACBs, so the cost of COVID-19 treatment for 14 - 28 days estimated at 75.7-77.3 million rupiah/patient. Whereas if the patient treated in ICU for 14 days and non ICU for 14 days, the rest of inpatient according to INACBs, the cost for COVID-19 treatment estimated at 130.4- 133.2 million rupiah/patient. The COVID-19 treatment is quite expensive and can be a burden for the Government of Indonesia's budget. In addition, the limited access and health facilities also become an obstacle. Strengthening promotive and preventive efforts are needed to prevent the surge of COVID-19 case. Policies which support strict social and physical distancing are needed so that the interventions become more effective. © The Authors, published by EDP Sciences, 2020.